Vertex Pharmaceuticals
VRTX
VRTX
813 hedge funds and large institutions have $53.4B invested in Vertex Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 165 funds opening new positions, 277 increasing their positions, 266 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 18 → 18 (0)
0.98% less ownership
Funds ownership: 95.92% → 94.94% (-0.98%)
5% less call options, than puts
Call options by funds: $369M | Put options by funds: $388M
Holders
813
Holding in Top 10
18
Calls
$369M
Puts
$388M
Top Buyers
| 1 | +$656M | |
| 2 | +$259M | |
| 3 | +$117M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$96.7M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$90.2M |
Top Sellers
| 1 | -$519M | |
| 2 | -$487M | |
| 3 | -$357M | |
| 4 |
ClearBridge Investments
New York
|
-$180M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$176M |